Key Metrics
Factor Lens
Seasonal Performance
Dividends
Per-share amounts adjusted for stock splits.
Last 12 Payouts
| Period | Ex-Date | Amount / Share |
|---|---|---|
| Q2 2026 | ~2026-06-30 | $0.7200 |
| Q1 2026 | ~2026-03-31 | $0.7200 |
| Q4 2025 | ~2025-12-30 | $0.7200 |
| Q3 2025 | ~2025-09-30 | $0.7200 |
| Q2 2025 | ~2025-06-30 | $0.7200 |
| Q1 2025 | ~2025-03-31 | $0.7200 |
| Q3 2024 | ~2024-09-30 | $0.7200 |
| Q2 2024 | ~2024-06-30 | $0.7200 |
Financial Trends
Revenue & Net Income
Earnings Per Share
Margins
Cash Flow
Company Overview
Labcorp Holdings Inc. is a global leader of innovative and comprehensive laboratory services that provides vital information to help doctors, hospitals, pharmaceutical companies,… researchers, and patients make clear and confident decisions. The Company provides insights and accelerates innovations to improve health and improve lives through its unparalleled diagnostics and drug development laboratory capabilities. During 2025, the Company's nearly 71,000 employees served clients in approximately 100 countries and performed more than 750 million tests for patients around the world. In addition, the Company provided support for more than 85% of the new drugs and therapeutic products approved in 2025 by the FDA. The Company operates two main business segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Company's strength in science, technology, and innovation, as well as its global scale, powers its continued success and enables it to play a leading role in advancing healthcare across the globe. Strategic priorities include being a partner of choice for health systems and regional laboratories, and leading in the development, licensing, and scaling of specialty testing across oncology, neurology, autoimmune disease, and women's health areas.
- Name
- Labcorp Holdings Inc.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- CEO
- Adam H. Schechter · Chairman, President, and Chief Executive Officer
- Employees
- 71,000 as of 2025-12-31
- IPO Date
- 2018-10-18
- Phone
- (336) 229-1127
- Address
- 358 South Main Street, Burlington, NC 27215
- Website
- http://www.labcorp.com
Key Executives
| Name | Title | FY Pay |
|---|---|---|
| Peter M. Neupert | Director | — |
| Paul B. Rothman, M.D. | Director | — |
| Kerrii B. Anderson | Director | — |
| Garheng Kong, M.D., Ph.D. | Vice Chairman and Lead Independent Director | — |
| Adam H. Schechter | Chairman, President, and Chief Executive Officer | — |
Latest News
- 2026-04-23
- 2026-04-22
- 2026-04-21
- 2026-04-21
- 2026-04-21
- 2026-04-21
- 2026-04-19
-
2026-04-16
Assetmark Inc. Boosts Stock Position in Labcorp Holdings Inc. $LH defenseworld.net